Viveve Medical Inc. (NASDAQ:VIVE) shares traded -69.77% lower at $0.26 on Wall Street last session.
In accordance with the data, 1 analysts cover Viveve Medical Inc. (NASDAQ:VIVE). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $6.25 and a low of $6.25, we find $6.25. Given the previous closing price of $0.86, this indicates a potential upside of 626.74 percent. VIVE stock price is now -47.19% away from the 50-day moving average and -63.10% away from the 200-day moving average. The market capitalization of the company currently stands at $2.63M.
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
Sponsored
It has been rated a hold by 0 analysts and a buy by 1. Brokers who have rated the stock have averaged $6.25 as their price target over the next twelve months.
With the price target of $10.75, Alliance Global Partners recently initiated with Buy rating for Viveve Medical Inc. (NASDAQ: VIVE). On July 23, 2019, Stifel Downgraded its previous ‘Buy’ rating to ‘Hold’ on the stock reducing its target price from $3 to quote $1, while ‘Raymond James’ rates the stock as ‘Mkt Perform’.
There have been several recent changes in the stakes of large investors in VIVE stock. In total, there are 21 active investors with 9.30% ownership of the company’s stock.
Viveve Medical Inc. (NASDAQ: VIVE) opened at $0.2717 on Tuesday. During the past 12 months, Viveve Medical Inc. has had a low of $0.35 and a high of $1.24. As of last week, the company has a debt-to-equity ratio of 4.67, a current ratio of 0.90, and a quick ratio of 0.70. The fifty day moving average price for VIVE is $0.4861 and a two-hundred day moving average price translates $0.7007 for the stock.
The latest earnings results from Viveve Medical Inc. (NASDAQ: VIVE) was released for Jun, 2022. According to the Medical Devices Company, earnings per share came in at -$0.67, inline with analysts’ expectations of -$0.67. This compares to -$0.55 EPS in the same period last year. The company reported revenue of $1.68 million for the quarter, compared to $1.62 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 4.21 percent. For the current quarter, analysts expect VIVE to generate $1.7M in revenue.
Viveve Medical Inc.(VIVE) Company Profile
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
